期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Optimization of Clostridium beijerinckii semi-solid fermentation of rape straw to produce butyric acid by genome analysis 被引量:1
1
作者 Hui Kou Jia Zheng +4 位作者 guangbin ye Zongwei Qiao Kaizheng Zhang Huibo Luo Wei Zou 《Bioresources and Bioprocessing》 2024年第1期316-331,共16页
Butyric acid is a volatile saturated monocarboxylic acid,which is widely used in the chemical,food,pharmaceutical,energy,and animal feed industries.This study focuses on producing butyric acid from pre-treated rape st... Butyric acid is a volatile saturated monocarboxylic acid,which is widely used in the chemical,food,pharmaceutical,energy,and animal feed industries.This study focuses on producing butyric acid from pre-treated rape straw using simultaneous enzymatic hydrolysis semi-solid fermentation(SEHSF).Clostridium beijerinckii BRM001 screened from pit mud of Chinese nongxiangxing baijiu was used.The genome of C.beijerinckii BRM001 was sequenced and annotated.Using rape straw as the sole carbon source,fermentation optimization was carried out based on the genomic analysis of BRM001.The optimized butyric acid yield was as high as 13.86±0.77 g/L,which was 2.1 times higher than that of the initial screening.Furthermore,under optimal conditions,non-sterile SEHSF was carried out,and the yield of butyric acid was 13.42±0.83 g/L in a 2.5-L fermentor.This study provides a new approach for butyric acid production which eliminates the need for detoxification of straw hydrolysate and makes full use of the value of fermentation waste residue without secondary pollution,making the whole process greener and more economical,which has a certain industrial potential. 展开更多
关键词 Butyric acid Clostridium beijerinckii Semi-solid non-sterile fermentation Rape straw Genome annotation
在线阅读 下载PDF
MEF2D在肺腺癌中的表达及与预后的相关性分析
2
作者 叶广彬 张忠伟 +3 位作者 李艳丽 高丽 黄伟 凌博 《中国肺癌杂志》 CAS CSCD 北大核心 2023年第7期538-544,共7页
背景与目的肌细胞增强因子2D(myocyte enhancer factor 2D,MEF2D)可以通过调控癌基因的转录参与肿瘤病变的进程。前期研究证实,MEF2D通过促进NUSAP1的转录,提高肺腺癌细胞A549和H1299的增殖和转移能力。本研究旨在探讨肺腺癌组织中MEF2... 背景与目的肌细胞增强因子2D(myocyte enhancer factor 2D,MEF2D)可以通过调控癌基因的转录参与肿瘤病变的进程。前期研究证实,MEF2D通过促进NUSAP1的转录,提高肺腺癌细胞A549和H1299的增殖和转移能力。本研究旨在探讨肺腺癌组织中MEF2D的表达水平及其临床意义。方法收集肺腺癌患者199例,采用免疫组化染色检测癌组织和癌旁组织中MEF2D的表达水平;整理患者病例资料和随访资料,研究MEF2D表达水平、临床指标和预后三者的相关性。结果肺腺癌患者中,癌组织MEF2D高表达率明显高于癌旁组织(P<0.05)。免疫组化结果分析发现,肺腺癌患者的癌组织中MEF2D表达水平与肿瘤分化程度、N分期、M分期和肺内转移具有相关性(P<0.05)。Kaplan-Meier分析证实,MEF2D低表达肺腺癌患者的预后优于高表达者(P<0.05)。Cox多因素分析表明,MEF2D表达水平、M分期、N分期和骨转移是影响肺腺癌患者预后的独立危险因素。结论MEF2D表达水平与肺腺癌的转移等临床特征关系密切,可作为患者预后的独立危险因素,可能是肺腺癌诊治的新靶点。 展开更多
关键词 肺肿瘤 MEF2D 预后 临床特征
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部